Abstract:Objective: To analyze the relationship between congenital heart disease (CHD) in newborns and maternal prenatal folic acid supplementation, as well as other high-risk factors. Method: A retrospective analysis was conducted on clinical data of 114 pregnant women diagnosed with congenital heart disease (CHD) in the prenatal stage at our hospital between January 2021 and January 2023. These pregnant women were included in the case group. Additionally, an equal number of pregnant women with normal examination results during the same period were selected as the control group at a 1:1 ratio. Basic information about the families of pregnant women and information about relevant exposure factors during the periconception period were analyzed based on survey forms previously completed by pregnant women during their prenatal check-ups at the hospital. Possible influencing factors were analyzed through multifactor logistic regression. Results: High-risk factors during the perinatal period for new CHD in newborns include maternal age at this pregnancy >35 years (OR=1.907), the presence of adverse pregnancy history (OR=2.213), a family history of CHD (OR=3.049), exposure to secondhand smoke during the perinatal period (OR=2.934), the use of cold medications (OR=1.719), fever (OR=2.034), exposure to noisy environments (OR=1.981), prolonged use of electronic devices (OR=1.827), consumption of pickled foods (OR=1.892). Prenatal folic acid supplementation is a protective factor for new CHD in newborns (OR=0.342). Conclusion: Pregnant women should choose an appropriate gestational age for conception. During the perinatal period, pregnant women should avoid exposure to the aforementioned high-risk factors as much as possible and supplement folic acid appropriately. It is essential to cultivate good dietary and lifestyle habits, as this has significant implications for preventing and reducing the occurrence of CHD in newborns. Healthcare professionals should prioritize educating pregnant women about the risks associated with the identified high-risk factors and emphasize the importance of early prenatal care. Furthermore, promoting appropriate folic acid supplementation during the periconception period should be an integral part of prenatal care protocols. By implementing these recommendations, healthcare providers can contribute to reducing the occurrence of CHD in newborns and improving maternal and infant health outcomes.

[Association Between Congenital Heart Disease and Maternal Disease in Early Pregnancy in Women of Childbearing Age].

Epidemiology, Prenatal Diagnosis, and Neonatal Outcomes of Congenital Heart Defects in Eastern China: a Hospital-Based Multicenter Study

A case -control study on the risk factors of congenital heart disease among perinatal infants

Association Between Congenital Heart Disease and Medication Taken During Pregnancy among Women of Childbearing Age

Advances on associations of exposure to air pollutants during pregnancy with congenital heart disease in offspring

[1:2 Matched Case-Control Study on the Risk Factors Related to Congenital Heart Disease During the Peri-Conceptional Period].

Association of Maternal Disease and Medication Use with the Risk of Congenital Heart Defects in Offspring: a Case-Control Study Using Logistic Regression with a Random-Effects Model

[Association Between Illness and Mental Status in Pregnant Women and Birth Defects].

Geographical and Socioeconomic Factors Influence the Birth Prevalence of Congenital Heart Disease: A Population-based Cross-sectional Study in Eastern China

Maternal Exposure to Life Events During Pregnancy and Congenital Heart Disease in Offspring: a Case-Control Study in a Chinese Population

Associated Maternal and Fetal Factors of Fetal Congenital Heart Diseases Diagnosed by Fetal Echocardiography

Case-control study of maternal risk factors for fetal congenital heart diseases

A Matched Case-Control Study on the Association Between Colds, Depressive Symptoms During Pregnancy and Congenital Heart Disease in Northwestern China

The prenatal weekly temperature exposure and neonatal congenital heart disease: a large population-based observational study in China

Associations of maternal upper respiratory tract infection/influenza during early pregnancy with congenital heart disease in offspring: evidence from a case-control study and meta-analysis

Pregnancy Outcomes and Relative Risk Factors among Chinese Women with Congenital Heart Disease.

OP26.06: Association Between Peri‐conceptional Multiple Nongenetic Risk Factors with Congenital Heart Disease

The relationship between congenital heart disease and pregnancy infection

The Relationship Between Congenital Heart Disease in Newborns and Maternal Prenatal Folic Acid Supplementation, and Analysis of Other High-Risk Factors

[A Meta-analysis on the Risk Factors of Perinatal Congenital Heart Disease in Chinese People].

Association between congenital heart disease and folic acid supplementation during periconceptional period among women of childbearing age in Shaanxi